Solid state characterization and crystallization are indispensable aspects of the pharmaceutical product lifecycle, influencing various stages from early development to commercialization. By placing emphasis on efficient screening, seamless transfer to formulation, speed to clinical studies, and strategic partnerships, pharmaceutical companies can optimize their development processes, reduce costs, and enhance the overall success of their drug product candidates. This infographic covers five essential considerations for solid-state characterization. Download now to learn more.